Announcing a new publication for Acta Materia Medica journal. Prostate cancer (PrCa) is the most prevalent urogenital cancer affecting men.

Wade, who turned 43 earlier this month, said his father’s journey with prostate cancer inspired him to see a doctor after experiencing stomach issues, cramps, and difficulty urinating. A tumor found ...

Bone metastases are at the center of advanced prostate cancer care, with over 90% of patients with metastatic prostate cancer expected to have bone involvement. 1 These metastatic ...

The new urine test looks at 18 genes that are linked to high-risk prostate cancer. Previous research showed that MPS2 could ...

Prostate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment ...

In a live event, Vinay Minocha, MD, discusses the addition of darolutamide to androgen deprivation therapy for in patients ...

A test for pee-based markers of prostate cancer has previously relied on an uncomfortable first step. A new study has ...

A study of men with a family history of prostate cancer has discovered an inherited form of prostate cancer. The inherited ...

I am a 66-year-old white male who is active and relatively healthy. I have recently been diagnosed with prostate cancer. One ...

First patient treated in Phase II portion of clinical trial in metastatic prostate cancer at the West Los Angeles Veterans Administration ...

INmune Bio (INMB) has an ongoing Phase I/II trial in men with metastatic castration-resistant prostate cancer. The Company announced the ...

The six biggest myths about prostate cancer – as it is named England’s most common cancer - There has been a 25 per cent ...